Jian Zhang
Fudan University · The International Peace Maternity & Child Health Hospital · International Peace Maternity and Child Health Hospital affiliated to Shanghai Jiao Tong University, School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jian Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:36 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07922096 · A First-in-human Study of SMP-656 in Subjects With Locally Advanced/ Metastatic HER2 Expressing or Mutated Solid TumorsChengdu SciMount Pharmatech Co., Ltd. · completed · HER2-Expressing Advanced Solid Tumors, HER2-Mutated Advanced Solid Tumors, Metastatic Solid Tumors · principal investigator
- N/ANCT07480694 · Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADCFudan University · not yet recruiting · Treatment Efficacy · principal investigator
- N/ANCT07279181 · TVS, SHG, and MRI in Uterine NicheInternational Peace Maternity and Child Health Hospital · completed · Uterine Niche · study chair
- N/ANCT06966141 · A Real World Study of Sacituzumab GovitecanFudan University · recruiting · Breast Cancer Metastatic, Treatment Outcome · principal investigator
- N/ANCT06639152 · Oil-based Vs. Water-based Contrast Medium in Hysterosalpingography for Infertile Women in Improving Fertility OutcomeInternational Peace Maternity and Child Health Hospital · completed · Infertility · principal investigator
- N/ANCT06620939 · The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps RecurrenceZhang Jian · not yet recruiting · Endometrial Polyp · principal investigator
- Ph3NCT06519370 · FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · active not recruiting · Triple Negative Breast Cancer · principal investigator
- Ph1NCT06493864 · A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Breast Cancer, Solid Tumor · principal investigator
- Ph2NCT06471205 · A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast CancerSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Triple-negative Breast Cancer · principal investigator
- Ph3NCT06449027 · Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.Changchun GeneScience Pharmaceutical Co., Ltd. · active not recruiting · Breast Cancer Subjects · principal investigator
- Ph1NCT06428331 · A Study of SKB518 in Patients With Advanced Solid TumorsSichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · recruiting · Advanced Solid Tumors · study chair
- Ph1NCT06426680 · A Study of the ILB-3101 in Patients with Advanced Solid TumorsInnolake Biopharm · recruiting · Advanced Solid Tumor · principal investigator
- Ph3NCT06419621 · PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCBiotheus Inc. · active not recruiting · Triple Negative Breast Cancer(TNBC) · study chair
- Ph2NCT06413615 · A Study of FDA022-BB05 in Advanced/Metastatic Solid TumorsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · unknown · Advanced Solid Tumor · principal investigator
- Ph1NCT06394622 · A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid TumorsFudan University · unknown · Solid Tumor · principal investigator
- Ph3NCT06382142 · A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Triple-Negative Breast Cancer · principal investigator
- Ph3NCT06331520 · NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC RegimensFudan University · completed · Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy · study chair
- Ph1NCT06299124 · A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid TumorsRegor Pharmaceuticals Inc. · active not recruiting · Breast Cancer, Advanced Solid Tumor · principal investigator
- Ph1NCT06182735 · CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaFudan University · unknown · Renal Cell Carcinoma · principal investigator
- Ph3NCT06143553 · Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast CancerShanghai Yizhong Pharmaceutical Co., Ltd. · unknown · Metastatic Breast Cancer (MBC) · principal investigator
- Ph1/Ph2NCT06064812 · A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.Forward Pharmaceuticals Co., Ltd. · recruiting · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV · principal investigator
- Ph2NCT06042894 · A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast CancerSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Breast Cancer · principal investigator
- Ph1NCT05952947 · HRYZ-T101 Injection for HPV18 Positive Solid TumorHRYZ Biotech Co. · recruiting · Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina · principal investigator
- Ph3NCT05949801 · Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart FailureZensun Sci. & Tech. Co., Ltd. · completed · Chronic Systolic Heart Failure · principal investigator
- Ph1/Ph2NCT05927779 · Study of TFX06 in Women With Advanced Breast Cancer.Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · unknown · ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer · principal investigator
- Ph1NCT05914376 · Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced TumorsHangzhou Converd Co., Ltd. · active not recruiting · Advanced Solid Tumors · principal investigator
- Ph1NCT05843305 · A Study of BPI-452080 in Subjects With Solid TumorsBetta Pharmaceuticals Co., Ltd. · unknown · Solid Tumor, Renal Cell Carcinoma, Von Hippel-Lindau Disease · principal investigator
- Ph1/Ph2NCT05842785 · TSN222 in Subjects With Advanced Solid Tumors or LymphomasTyligand Bioscience (Shanghai) Limited · unknown · Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma · principal investigator
- Ph1/Ph2NCT05803018 · A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological MalignanciesSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Gynecological Malignant Tumor, Solid Tumor · principal investigator
- Ph1NCT05798533 · Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)BGI, China · unknown · Solid Tumor · principal investigator
- Ph1NCT05787535 · HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid TumorHRYZ Biotech Co. · unknown · Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer · principal investigator
- Ph1/Ph2NCT05744427 · Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid TumorsJiangsu Alphamab Biopharmaceuticals Co., Ltd · active not recruiting · Advanced Solid Tumor · principal investigator
- Ph1NCT05707676 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001)L & L Bio Co., Ltd., Ningbo, China · terminated · Solid Tumor · principal investigator
- Ph1NCT05631964 · Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Locally Advanced or Metastatic Digestive Tract Tumors, Other Solid Tumors · principal investigator
- N/ANCT05510037 · Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic LesionsFudan University · completed · Breast Cancer · principal investigator
- Ph1NCT05475847 · Study of C-TIL052A Cell Therapy in Advanced Cervical CancerFudan University · unknown · Cervical Cancer · principal investigator
- Ph1NCT05470348 · A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Breast Cancer, Solid Tumor · principal investigator
- Ph1/Ph2NCT05416749 · A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid TumorsMabwell (Shanghai) Bioscience Co., Ltd. · suspended · Solid Tumors · principal investigator
- Ph1NCT05394168 · A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid TumorsShanghai Henlius Biotech · unknown · Advanced/Metastatic Solid Tumors · principal investigator
- Ph1NCT05337657 · A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast CancerGenor Biopharma Co., Ltd. · unknown · Advanced Breast Cancer · principal investigator
- Ph1NCT05221385 · Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin LymphomaChangchun GeneScience Pharmaceutical Co., Ltd. · terminated · Solid Tumor, Non-Hodgkin Lymphoma · principal investigator
- Ph1NCT05174637 · A Study of FDA018-ADC in Patients With Advanced Solid TumorsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · active not recruiting · Advanced/ Metastatic Solid Tumors · principal investigator
- Ph2NCT05097209 · Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal CarcinomaWei Jiang · unknown · Nasopharyngeal Carcinoma · principal investigator
- Ph1/Ph2NCT05048160 · A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant NeoplasmMabwell (Shanghai) Bioscience Co., Ltd. · unknown · Advanced Malignant Neoplasm · principal investigator
- Ph1NCT04818632 · AZD9833 China PK StudyAstraZeneca · completed · ER+, HER2-, Metastatic Breast Cancer · principal investigator
- Ph1NCT04742036 · Capivasertib China PK StudyAstraZeneca · completed · Advanced Solid Tumours · principal investigator
- Ph2NCT04517292 · Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)Fudan University · unknown · Breast Cancer · principal investigator
- Ph2NCT04508803 · Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast CancerFudan University · completed · Treatment Efficacy · principal investigator
- N/ANCT04446819 · Compression Gloves to Reduce Albumin-binding Paclitaxel Induced Peripheral Sensory and Motor Neurotoxicity (REMAINING)Fudan University · unknown · Peripheral Neuropathy · principal investigator
- Ph2NCT04303988 · A Phase II Study of Triple-negative Breast Cancer Brain Metastases.Fudan University · unknown · Breast Cancer · principal investigator
- Ph2NCT04192903 · Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast CancerFudan University · unknown · Triple-negative Breast Cancer · principal investigator
- Ph4NCT04028544 · The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure PatientsChinese Academy of Medical Sciences, Fuwai Hospital · unknown · Heart Failure · study chair
- Ph1NCT03159585 · To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsZhujiang Hospital · completed · Liver Cancer Stage IV, Gastric Cancer Stage IV, Esophageal Cancer, Stage IV · study chair
- N/ANCT02870985 · BIOTRONIK Orsiro Pre-Marketing RegistrationBiotronik (Beijing) Medical Device Ltd. · completed · Coronary Artery Disease · principal investigator
- Ph1NCT02808416 · Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)Guangdong 999 Brain Hospital · completed · Brain Cancer, Neoplasm Metastases · principal investigator
- Ph1NCT02808364 · Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)Guangdong 999 Brain Hospital · completed · Glioblastoma · principal investigator
- Ph1NCT02709616 · Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)Guangdong 999 Brain Hospital · completed · Glioblastoma · principal investigator
- N/ANCT02666755 · Novel Detection System for Lung Cancer Curative Effect MonitoringJian Zhang · unknown · Lung Neoplasms · study director
- N/ANCT02664818 · Study of China Heart Failure Registry to Investigate Characteristics of Patients in ChinaChinese Academy of Medical Sciences, Fuwai Hospital · unknown · Heart Failure · study chair
- Ph2NCT02024373 · Effect and Safety Study of Atorvastatin to Treat Chronic Subdural HematomaOriental Neurosurgery Evidence-Based-Study Team · completed · Chronic Subdural Hematoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 117 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Metabolic dysregulation and therapeutic intervention in asthmaR21AI117547 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · fiscal years 2015 to 2016 · $226,950 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:36 UTC. The ranking covers the 200 most relevant of 4271 PubMed records, and a shared surname and initials can bring in a namesake. All 4271 on PubMed
- 163 citationsRCR 33.1
- 47 citationsRCR 7.3
- Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.Ann Oncol · 202645 citationsRCR 22.5
- Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.Ann Oncol · 202637 citationsRCR 18.5
- 31 citationsRCR 8.0
- Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery: The BP-CARES Randomized Trial.J Am Coll Cardiol · 202530 citationsRCR 13.9
- Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents: A Phase 3 Randomized Clinical Trial.JAMA Dermatol · 202524 citationsRCR 7.3
- Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels.Gut Microbes · 202524 citationsRCR 7.4
- Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA.J Thorac Oncol · 202522 citationsRCR 4.3
- 22 citationsRCR 11.0